SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Doti AI raises $7M Seed round to help enterprises securely access and utilize internal data

Greylock appoints Mor Chen as partner to lead Israeli investments

Full list of Israeli high-tech funding rounds in 2025

Eleos doubles in value as it raises $60 million to disrupt behavioral healthcare

Buzz

Most popular

Daily

Weekly

1

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

2

"Everyone will be a manager" - what the world of work will look like with AI agents

3

Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M

4

What went wrong at AnyVision? Lessons from a $352M flameout

5

Mitiga raises $30M Series B to defend cloud services from cyberattacks

Gamida Cell

5 stories about Gamida Cell

ג'וליאן אדמס מנכ"ל גמידה

Gamida Cell announces $75 million financing with Highbridge Capital Management

The Israeli company is developing and commercializing cures for blood cancers and serious hematologic diseases

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer

The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share

נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer

The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms

נאסד"ק וול סטריט

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich

The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor